No effect of epigallocatechin-3-gallate with weight loss on adiposity reduction, cardiometabolic risk factors and liver function in pre-menopausal obese women.

Kawada, Tomoyuki.
Br J Nutr; 112(9): 1586, 2014 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-25247887